Related Experiment Videos
Strain variation and nuclear association of Newcastle disease virus matrix protein
1Department of Immunology/Microbiology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612.
Abstract:
Five monoclonal antibodies to the matrix (M) protein of Newcastle disease virus (NDV) Australia-Victoria (AV) strain were generated and characterized. In competitive antibody-binding assays, the antibodies fell into three discrete groups. The antigenic sites described by these antibody groups were designated M1, M2, and M3. Each antibody reacted with a panel of NDV strains in a manner unique to its group, confirming the grouping by competitive antibody binding. Only site M1 was found on all 12 of the strains tested and may be a "pan-NDV" epitope. A large portion of the M protein of strain AV was detected in the nuclei of infected cells by all five monoclonal antibodies. In addition, the antibodies only stained the nuclei of cells infected with NDV strains expressing M protein containing the corresponding antigenic site. These results confirm that the immunoreactivity in the nucleus is actually caused by the M protein and not by a cross-reacting host protein induced by viral infection.
Insights
Researchers developed five monoclonal antibodies to study Newcastle disease virus (NDV) matrix protein. One epitope (M1) is present on all tested NDV strains, indicating its potential as a universal target.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Newcastle disease virus (NDV) is a significant avian pathogen.
- The matrix (M) protein is a key structural component of NDV.
- Understanding NDV antigenic sites is crucial for vaccine development and diagnostics.
Purpose of the Study:
- To generate and characterize monoclonal antibodies against the NDV matrix (M) protein.
- To identify and map antigenic sites on the NDV M protein.
- To investigate the cellular localization of the NDV M protein.
Main Methods:
- Generation and characterization of five monoclonal antibodies specific to NDV M protein.
- Competitive antibody-binding assays to group antibodies and define antigenic sites (M1, M2, M3).
- Immunofluorescence staining to determine the cellular localization of M protein in infected cells.
Main Results:
- Monoclonal antibodies clustered into three groups, defining three distinct antigenic sites (M1, M2, M3).
- Epitope M1 was conserved across all 12 tested NDV strains, suggesting it is a pan-NDV epitope.
- The NDV M protein was localized to the nuclei of infected cells, confirmed by antibody staining.
Conclusions:
- The study successfully mapped antigenic sites on the NDV M protein using monoclonal antibodies.
- The conserved M1 epitope represents a potential target for broad-spectrum NDV diagnostics and vaccines.
- Nuclear localization of the M protein was confirmed, ruling out cross-reactivity with host proteins.